{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q16473",
      "entity_text" : "Xa",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:9875401",
      "entity_text" : "rivaroxaban",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "As observed with factor Xa alone, in the presence of prothrombinase components, rivaroxaban and apixaban inhibited over 95% of factor Xa chromogenic activity in the same dose dependent manner (not shown) with K i values of 1.0 +/- 0.6 nM and 0.9 +/- 0.8 nM, respectively, values not significantly different from those determined with free factor Xa.",
  "reading_complete" : "2020-08-03T13:32:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:29:22Z",
  "trigger" : "inhibited",
  "evidence" : [ "rivaroxaban and apixaban inhibited over 95% of factor Xa chromogenic activity in the same dose-dependent manner (not shown) with K\n i \nvalues of 1.0 +/- 0.6 nM and 0.9 +/- 0.8 nM, respectively, values not significantly different from those determined with free factor Xa" ],
  "pmc_id" : "6524873",
  "score" : 0
}